ELMT Stock Analysis: The Elmet Co. Common Stock | NASDAQ
Aerospace & Defense | NASDAQ, USA | Market Cap: 523m USD | 12M Return: -6.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 11.4M
Warnings
Tailwinds
Seasonality 0.2 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Elmet Group Co. (NASDAQ: ELMT) manufactures precision-engineered components and high-energy systems through two divisions: Critical Materials Components and Engineered Microwave Products. It supplies refractory metals such as tungsten, molybdenum, niobium, and tantalum, which are valued for their exceptionally high melting points and density and are commonly specified for extreme-temperature and high-stress applications. The company also produces radio frequency and microwave components-including waveguides, circulators, loads, pressure windows, and automatic tuning systems-for radar, missile tracking, directed energy, semiconductor fabrication, and fusion research applications across the aerospace, defense, industrial, medical, and energy sectors. Elmet was incorporated in 2024 and is headquartered in Portland, Maine.
- Defense radar and directed energy orders accelerate
- Critical refractory metals pricing benefits from supply concentration
- Semiconductor capex recovery drives microwave components demand
| Net Income: -247k TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 0.96 > 1.0 |
| NWC/Revenue: 24.48% < 20% (prev 26.17%; Δ -1.68% < -1%) |
| CFO/TA 0.16 > 3% & CFO 29.1m > Net Income -247k |
| Net Debt (69.6m) to EBITDA (6.65m): 10.46 < 3 |
| Current Ratio: 1.73 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (30.0m) vs prev 1.69% < -2% |
| Gross Margin: 19.62% > 18% (prev 21.15%; Δ -1.53% > 0.5%) |
| Asset Turnover: 112.9% > 50% (prev 109.1%; Δ 3.80% > 0%) |
| Interest Coverage Ratio: 0.29 > 6 (EBIT TTM 1.15m / Interest Expense TTM 3.91m) |
| A: 0.27 (Total Current Assets 118.6m - Total Current Liabilities 68.6m) / Total Assets 187.2m |
| B: 0.24 (Retained Earnings 45.0m / Total Assets 187.2m) |
| C: 0.01 (EBIT TTM 1.15m / Avg Total Assets 180.9m) |
| D: 0.48 (Book Value of Equity 61.0m / Total Liabilities 126.2m) |
| Altman-Z'' = 3.09 = A |
| DSRI: 0.90 (Receivables 33.0m/34.3m, Revenue 204.3m/190.4m) |
| GMI: 1.08 (GM 21.15% / 19.62%) |
| AQI: 0.69 (AQ_t 0.07 / AQ_t-1 0.11) |
| SGI: 1.07 (Revenue 204.3m / 190.4m) |
| TATA: -0.16 (NI -247k - CFO 29.1m) / TA 187.2m) |
| Beneish M = -3.19 (Cap -4..+1) = AA |
As of July 10, 2026, the stock is trading at USD 15.82 with a total of 431,066 shares traded. Over the past week, the price has changed by -17.82%, over one month by -15.67%, over three months by -6.94% and over the past year by -6.94%.
Current recommended Stop Loss: 13.70 (which is 13.4% or 1.3 ATR below the current price).
The Elmet Co. Common Stock has no consensus analysts rating.
P/E Forward = 39.2157
P/S = 2.4735
P/B = 8.5748
Revenue TTM = 204.3m USD
EBIT TTM = 1.15m USD
EBITDA TTM = 6.65m USD
Long Term Debt = 41.8m USD (from longTermDebt, last quarter)
Short Term Debt = 9.52m USD (from shortTermDebt, last quarter)
Debt = 72.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 10.9m
Net Debt = 69.6m USD (calculated: Debt 72.2m - CCE 2.66m)
Enterprise Value = 592.1m USD (522.5m + Debt 72.2m - CCE 2.66m)
Interest Coverage Ratio = 0.29 (Ebit TTM 1.15m / Interest Expense TTM 3.91m)
EV/FCF = 30.85x (Enterprise Value 592.1m / FCF TTM 19.2m)
FCF Yield = 3.24% (FCF TTM 19.2m / Enterprise Value 592.1m)
FCF Margin = 9.40% (FCF TTM 19.2m / Revenue TTM 204.3m)
Net Margin = -0.12% (Net Income TTM -247k / Revenue TTM 204.3m)
Gross Margin = 19.62% ((Revenue TTM 204.3m - Cost of Revenue TTM 164.2m) / Revenue TTM)
Gross Margin QoQ = 20.62% (prev 20.29%)
Tobins Q-Ratio = 3.16 (Enterprise Value 592.1m / Total Assets 187.2m)
Interest Expense / Debt = 5.41% (Interest Expense 3.91m / Debt 72.2m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 907k (EBIT 1.15m * (1 - 21.00%))
Current Ratio = 1.73 (Total Current Assets 118.6m / Total Current Liabilities 68.6m)
Debt / Equity = 1.18 (Debt 72.2m / totalStockholderEquity, last quarter 61.0m)
Debt / EBITDA = 10.46 (Net Debt 69.6m / EBITDA 6.65m)
Debt / FCF = 3.62 (Net Debt 69.6m / FCF TTM 19.2m)
Total Stockholder Equity = 82.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.14% (Net Income -247k / Total Assets 187.2m)
RoE = -0.30% (Net Income TTM -247k / Total Stockholder Equity 82.9m)
RoCE = 0.92% (EBIT 1.15m / Capital Employed (Equity 82.9m + L.T.Debt 41.8m))
RoIC = 0.72% (NOPAT 907k / Invested Capital 125.5m)
WACC = 11.35% (E(522.5m)/V(594.8m) * Re(12.33%) + D(72.2m)/V(594.8m) * Rd(5.41%) * (1-Tc(0.21)))
Discount Rate = 12.33% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 25.82 | Cagr: 3.93%
[DCF] Terminal Value 68.90% ; FCFF base≈18.0m ; Y1≈20.6m ; Y5≈30.4m
[DCF] Fair Price = 7.63 (EV 298.2m - Net Debt 69.6m = Equity 228.6m / Shares 30.0m; r=11.35% [WACC]; 5y FCF grow 15.0% → 2.50% )
Revenue Correlation: N/A | Revenue CAGR: N/A | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.06 | Chg30d=+129.84% | Revisions=+0% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.12 | Chg30d=+16.17% | Revisions=+0% | Analysts=3
EPS current Year (2026-12-31): EPS=0.42 | Chg30d=+259.57% | Revisions=+0% | GrowthEPS=+0.0% | GrowthRev=+18.2%
EPS next Year (2027-12-31): EPS=0.54 | Chg30d=+8.59% | Revisions=+0% | GrowthEPS=+27.2% | GrowthRev=+9.2%
[Analyst] Revisions Ratio: +0% (up=0, down=0)